Research Article
Evaluation of Human Respiratory Syncytial Virus and Human Parainfluenza Virus Type 3 among Hospitalized Children in Northwest of Iran
Table 3
Association of symptoms with respiratory syncytial virus infection and parainfluenza 3.
| Clinical manifestations of patients | RSV | HPIV | Positive | Negative | value | Positive | Negative | value |
| Wheezing | | | 0.003 | | | 0.28 | Yes | 12 (33.3%) | 24 (66.7%) | | 0 (0%) | 36 (100%) | | No | 6 (9.4%) | 58 (90.6%) | | 2 (3.1%) | 62 (96.9%) | | Fever | | | 0.17 | | | 0.33 | Yes | 10 (14.5%) | 59 (85.5%) | | 2 (2.9%) | 67 (97.1%) | | No | 8 (25.5%) | 23 (74.2%) | | 0 (0.0%) | 31 (100%) | | Vomiting | | | 0.46 | | | 0.79 | Yes | 6 (14.6%) | 35 (85.4%) | | 1 (2.4%) | 40 (97.6%) | | No | 12 (20.3%) | 47 (97.7%) | | 1 (1.7%) | 58 (98.3%) | | Diarrhea | | | 0.12 | | | 0.23 | Yes | 1 (5.6%) | 17 (94.4%) | | 1 (5.6%) | 17 (94.4%) | | No | 17 (20.7%) | 65 (79.3%) | | 1 (1.2%) | 81 (98.8%) | | Pneumonia | | | 0.08 | | | 0.25 | Yes | 6 (31.6%) | 13 (68.4%) | | 1 (5.3%) | 18 (94.7%) | | No | 12 (14.8%) | 69 (85.2%) | | 1 (1.2%) | 80 (98.8%) | | Cough | | | 0.21 | | | 0.39 | Yes | 11 (15.1%) | 62 (84.9%) | | 2 (2.7%) | 72 (97.3%) | | No | 7 (25.9%) | 20 (74.1%) | | 0 (0%) | 26 (100%) | | Runny nose | | | 0.10 | | | 0.88 | Yes | 5 (11.1%) | 40 (88.9%) | | 1 (2.2%) | 44 (97.8%) | | No | 13 (23.6%) | 42 (76.4%) | | 1 (1.8%) | 54 (98.2%) | | Cyanosis | | | 0.63 | | | 0.83 | Yes | 0 (0%) | 1 (100%) | | 0 (0%) | 2 (100%) | | No | 18 (18.2%) | 81 (81.8%) | | 2 (2%) | 96 (98%) | | Tachypnea | | | 0.005 | | | 0.69 | Yes | 4 (57.1%) | 3 (42.9%) | | 0 (0%) | 7 (100%) | | No | 14 (15.1%) | 79 (84.9%) | | 2 (2.2%) | 91 (97.8%) | | Shortness of breath | | | 0.85 | | | 0.016 | Yes | 5 (19.2%) | 21 (80.8%) | | 2 (7.7%) | 24 (92.3%) | | No | 14 (17.6%) | 61 (82.4%) | | 0 (0%) | 74 (100%) | |
|
|
Abbreviations. RSV: respiratory syncytial virus; HPIV-3: human parainfluenza virus 3.
|